Craig A. Collard, Director at Sierra Oncology, Inc. (SRRA), bought 27,000 shares at $22.95 ($622K) on 2021-11-23, disclosed to the SEC on 2021-11-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Several strong factors at once. The rarest rating we give.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.95 | 5,601 | $129K | 20.7% |
| 2 | $22.95 | 5,601 | $129K | 20.7% |
| 3 | $23.09 | 7,899 | $182K | 29.3% |
| 4 | $23.09 | 7,899 | $182K | 29.3% |
| Total | $23.03 avg | 27,000 | $622K | 100% |
| Filing → |
| OPNT | BUY | 2022-05-17 | $368K | — | Filing → |
| OPNT | BUY | 2022-05-16 | $39K | — | Filing → |
| OPNT | BUY | 2021-09-15 | $45K | — | Filing → |